# Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma

> **NCT01425736** · PHASE2 · COMPLETED · sponsor: **Wei Guo** · enrollment: 91 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Chemotherapy
- **DRUG:** Nimotuzumab and Chemotherapy

## Key facts

- **NCT ID:** NCT01425736
- **Lead sponsor:** Wei Guo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-01
- **Final completion:** 2013-03
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2014-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425736, "Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT01425736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*